The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

289

Participants

Timeline

Start Date

October 18, 2018

Primary Completion Date

May 30, 2020

Study Completion Date

November 18, 2022

Conditions
Recurrent or Metastatic NPC
Interventions
BIOLOGICAL

TORIPALIMAB INJECTION(JS001 ) combine with chemotherapy

TORIPALIMAB INJECTION(JS001 ) combine with chemotherapy

DRUG

Placebos

placebo combine with chemotherapy

Trial Locations (32)

112

Taipei Veterans General Hospital, Taipei

333

Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital, Taoyuan District

404

China Medical University Hospital, Taichung

704

National Cheng Kung University Hospital, Tainan City

40705

TaiChung Veterans General Hospital, Taichung

50011

Hebei Oncology Hospital, Shijiazhuang

100021

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing

130012

Affiliated Hospital of Guangdong Medical University, Zhanjiang

169610

National Cancer Centre, Singapore

200032

Fudan University Cancer Hospital, Shanghai

200080

Shanghai General Hospital, Shanghai

210000

Jiangsu Oncology Hospital, Nanjing

308433

Tan Tock Seng Hospital, Singapore

310022

Zhejiang Cancer Hospital, Hangzhou

330029

Jiangxi Cancer Hospital, Nanchang

350000

Fujian Medical University Union Hospital, Fuzhou

Fujian Provincial Cancer Hospital, Fuzhou

410011

The Second Xiangya Hospital of Central South University, Changsha

410013

Hunan Cancer Hospital, Changsha

430023

Union Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology, Wuhan

430030

Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science & TechnologyTongji Hospital, Wuhan

510060

Sun Yat-Sen University Cancer Center, Guangzhou

510095

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou

510515

Nanfang Hospital, Guangzhou

515031

Cancer Hospital of Shantou University Medical College, Shantou

518020

Shenzhen People's Hospital, Shenzhen

519000

The Fifth Affiliated Hospital Sun Yat-Sen University - Medical Oncology, Zhuhai

530021

The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning

545000

Liuzhou Worker's Hospital, Liuzhou

550000

The Affiliated Cancer Hospital of Guizhou Medical University, Guiyang

570311

Hainan General Hospital (Hainan Province People's Hospital), Haikou

610041

West China Hospital, Sichuan University, Chengdu

All Listed Sponsors
lead

Shanghai Junshi Bioscience Co., Ltd.

OTHER

NCT03581786 - The Efficacy and Safety Study of TORIPALIMAB INJECTION Combined With Chemotherapy for Nasophapyngeal Cancer | Biotech Hunter | Biotech Hunter